C

Concord Biotech Ltd
NSE:CONCORDBIO

Watchlist Manager
Concord Biotech Ltd
NSE:CONCORDBIO
Watchlist
Price: 1 680.6 INR -2.32% Market Closed
Market Cap: 175.8B INR

Intrinsic Value

The intrinsic value of one CONCORDBIO stock under the Base Case scenario is 1 077.75 INR. Compared to the current market price of 1 680.6 INR, Concord Biotech Ltd is Overvalued by 36%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CONCORDBIO Intrinsic Value
1 077.75 INR
Overvaluation 36%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation History
Concord Biotech Ltd

CONCORDBIO
Valuation History
HIDDEN
Show
Valuation History Unavailable

Historical valuation for CONCORDBIO cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%

Fundamental Analysis

Concord Biotech Ltd
NSE:CONCORDBIO
IN
Pharmaceuticals
Market Cap
175.8B INR
IPO
Aug 18, 2023
IN
Pharmaceuticals
Market Cap
175.8B INR
IPO
Aug 18, 2023
Price
â‚ąfalse
EPS
â‚ąfalse
Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about CONCORDBIO?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Concord Biotech Ltd
Financials
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Concord Biotech Ltd

Balance Sheet Decomposition
Concord Biotech Ltd

Current Assets 9.3B
Cash & Short-Term Investments 3.2B
Receivables 3.4B
Other Current Assets 2.7B
Non-Current Assets 8.3B
Long-Term Investments 95.5m
PP&E 8.1B
Intangibles 7.8m
Other Non-Current Assets 133.3m
Efficiency

Free Cash Flow Analysis
Concord Biotech Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Concord Biotech Ltd

Revenue
10.9B INR
Cost of Revenue
-2.7B INR
Gross Profit
8.2B INR
Operating Expenses
-4.3B INR
Operating Income
4B INR
Other Expenses
-704.5m INR
Net Income
3.3B INR
Fundamental Scores

CONCORDBIO Profitability Score
Profitability Due Diligence

Concord Biotech Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Year Average ROIC
Positive Operating Income
Positive 3-Year Average ROE
67/100
Profitability
Score

Concord Biotech Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.

CONCORDBIO Solvency Score
Solvency Due Diligence

Concord Biotech Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Concord Biotech Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CONCORDBIO Price Targets Summary
Concord Biotech Ltd

Wall Street analysts forecast CONCORDBIO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 1 914.29 INR with a low forecast of 1 636.2 INR and a high forecast of 2 296.35 INR.

Lowest
Price Target
1 636.2 INR
3% Downside
Average
Price Target
1 914.29 INR
14% Upside
Highest
Price Target
2 296.35 INR
37% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CONCORDBIO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

CONCORDBIO Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one CONCORDBIO stock?

The intrinsic value of one CONCORDBIO stock under the Base Case scenario is 1 077.75 INR.

Is CONCORDBIO stock undervalued or overvalued?

Compared to the current market price of 1 680.6 INR, Concord Biotech Ltd is Overvalued by 36%.

Back to Top